Effectiveness and safety of direct oral anticoagulants among patients with non-valvular atrial fibrillation and liver disease: A multinational cohort study-Reference-Cited by-同舟云学术

Effectiveness and safety of direct oral anticoagulants among patients with non-valvular atrial fibrillation and liver disease: A multinational cohort study

Published:2024-05 Issue: Volume:237 Page:71-78
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Douros Antonios^ORCID,Cui Ying,Platt Robert W.,Filion Kristian B.,Sebastiani Giada,Renoux Christel

Funder

Fonds de Recherche du Québec - Santé

McGill University

Canadian Institutes of Health Research

Publisher

Elsevier BV

Reference44 articles.

1. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the Management of Patients with Atrial Fibrillation;January;Circulation,2019

2. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS;Kirchhof;Eur. Heart J.,2016

3. Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation;Alonso;Heart,2017

4. Non-vitamin K antagonist Oral anticoagulants and risk of serious liver injury;Douros;J. Am. Coll. Cardiol.,2018

5. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF);Kirchhof;Europace,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH;Journal of Thrombosis and Haemostasis;2024-09

2. Patients with atrial fibrillation and common exclusion criteria from clinical trials are at high risk of clinical events: the Murcia AF Project II (MAFP-II) cohort study;Internal and Emergency Medicine;2024-07-04

3. Effectiveness of Direct Oral Anticoagulants and Vitamin K Antagonists in Preventing Stroke in Patients With Atrial Fibrillation and Liver Cirrhosis: A Systematic Review and Meta-Analysis;Cureus;2024-06-18